Jonathan Kay to Antibodies, Antinuclear
This is a "connection" page, showing publications Jonathan Kay has written about Antibodies, Antinuclear.
Connection Strength
0.250
-
Baecklund E, Backlin C, R?nnelid J, Toes R, Huizinga T, ?hlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. Scand J Rheumatol. 2018 07; 47(4):270-275.
Score: 0.147
-
Schneeberger D, Tyndall A, Kay J, S?ndergaard KH, Carreira PE, Morgiel E, Deuschle K, Derk CT, Widuchowska M, Walker UA. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford). 2013 Mar; 52(3):560-7.
Score: 0.103